Literature DB >> 1510408

Ofloxacin versus doxycycline for treatment of cervical infection with Chlamydia trachomatis.

T M Hooton1, B E Batteiger, F N Judson, S L Spruance, W E Stamm.   

Abstract

Women with culture-proven Chlamydia trachomatis cervical infection were randomized to receive either ofloxacin (300 mg) or doxycycline (100 mg), orally twice daily for 7 days. All 56 had negative cultures 5 to 9 days after treatment. Four weeks after treatment, 26 (93%) of 28 ofloxacin-treated patients and all 22 doxycycline-treated patients were cured. We conclude that 300 mg of ofloxacin given twice daily for 7 days provides effective therapy for chlamydial infection of the cervix.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1510408      PMCID: PMC188853          DOI: 10.1128/AAC.36.5.1144

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

Review 1.  Treatment of genitourinary tract infections with fluoroquinolones: clinical efficacy in genital infections and adverse effects.

Authors:  D C Hooper; J S Wolfson
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191

Review 2.  Treatment of genitourinary tract infections with fluoroquinolones: activity in vitro, pharmacokinetics, and clinical efficacy in urinary tract infections and prostatitis.

Authors:  J S Wolfson; D C Hooper
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191

3.  Ciprofloxacin compared with doxycycline for nongonococcal urethritis. Ineffectiveness against Chlamydia trachomatis due to relapsing infection.

Authors:  T M Hooton; M E Rogers; T G Medina; L E Kuwamura; C Ewers; P L Roberts; W E Stamm
Journal:  JAMA       Date:  1990-09-19       Impact factor: 56.272

4.  Mucopurulent cervicitis--the ignored counterpart in women of urethritis in men.

Authors:  R C Brunham; J Paavonen; C E Stevens; N Kiviat; C C Kuo; C W Critchlow; K K Holmes
Journal:  N Engl J Med       Date:  1984-07-05       Impact factor: 91.245

5.  Efficacy of ofloxacin in the treatment of non-gonococcal urethritis in men and genital infections caused by Chlamydia trachomatis in men and women.

Authors:  A T Nayagam; G L Ridgway; J D Oriel
Journal:  J Antimicrob Chemother       Date:  1988-09       Impact factor: 5.790

6.  Comparison of ofloxacin with doxycycline in the treatment of non-gonococcal urethritis and cervical chlamydial infection.

Authors:  V S Kitchen; C Donegan; H Ward; B Thomas; J R Harris; D Taylor-Robinson
Journal:  J Antimicrob Chemother       Date:  1990-11       Impact factor: 5.790

7.  Evaluation of ofloxacin in the treatment of mucopurulent cervicitis: response of chlamydia-positive and chlamydia-negative forms.

Authors:  V Chandeying; S Sutthijumroon; S Tungphaisal
Journal:  J Med Assoc Thai       Date:  1989-06

8.  Randomized comparison of ofloxacin and doxycycline for chlamydia and ureaplasma urethritis and cervicitis.

Authors:  W J Mogabgab; B Holmes; M Murray; R Beville; F B Lutz; K J Tack
Journal:  Chemotherapy       Date:  1990       Impact factor: 2.544

  8 in total
  12 in total

1.  Control of genital chlamydial infection.

Authors:  P R Gully; R W Peeling
Journal:  Can J Infect Dis       Date:  1994-05

Review 2.  Concurrent gonococcal and chlamydial infection: how best to treat.

Authors:  A J Robinson; G L Ridgway
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

Review 3.  Drug therapies for sexually transmitted diseases. Clinical and economic considerations.

Authors:  W R Bowie
Journal:  Drugs       Date:  1995-04       Impact factor: 9.546

Review 4.  Chlamydia trachomatis in adolescents and adults. Clinical and economic implications.

Authors:  C A Marra; D M Patrick; R Reynolds; F Marra
Journal:  Pharmacoeconomics       Date:  1998-02       Impact factor: 4.981

5.  Persistence of Chlamydia trachomatis is induced by ciprofloxacin and ofloxacin in vitro.

Authors:  U Dreses-Werringloer; I Padubrin; B Jürgens-Saathoff; A P Hudson; H Zeidler; L Köhler
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

Review 6.  Quinolones in sexually transmitted diseases.

Authors:  G L Ridgway
Journal:  Drugs       Date:  1993       Impact factor: 9.546

Review 7.  Quinolones in intracellular infections.

Authors:  J C Pechère
Journal:  Drugs       Date:  1993       Impact factor: 9.546

Review 8.  Ofloxacin. A reappraisal of its use in the management of genitourinary tract infections.

Authors:  S V Onrust; H M Lamb; J A Balfour
Journal:  Drugs       Date:  1998-11       Impact factor: 9.546

9.  Periodic health examination, 1996 update: 2. Screening for chlamydial infections. Canadian Task Force on the Periodic Health Examination.

Authors:  H D Davies; E E Wang
Journal:  CMAJ       Date:  1996-06-01       Impact factor: 8.262

Review 10.  Quinolones in sexually transmitted diseases. Global experience.

Authors:  G L Ridgway
Journal:  Drugs       Date:  1995       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.